Skip to main content

Advertisement

SpringerLink
Log in

Symptomatic management and imaging of brain metastases

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Summary

Brain metastasis is the most common malignancy of the nervous system. Survival is short and the majority of patients die within 5 months after diagnosis. In this review, clinical and pathophysiological aspects of brain metastases are described, including novel radiological methods as triple-dose gadolinium-enhanced MRI. Recursive partitioning analysis is a powerful tool to analyse prognosis, and recent studies contribute to subgroup division. Subsequently, treatment choices can be made, based on prognostic characteristics of the individual patient. Commonly, symptomatic therapy starts with the administration of corticosteroids, often resulting in improvement of neurological deficit. Anticonvulsants are administered in patients with symptomatic epilepsy. The risk on vascular complications in patients with brain metastases is increased and needs special attention. Treatment of psychiatric complications e.g. delirium or depression may also improve quality of life.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. P Boyle P Autier H Bartelink J Baselga P Boffetta J Burn HJ Burns L Christensen L Denis M Dicato V Diehl R Doll S Franceschi CR Gillis N Gray L Griciute A Hackshaw M Kasler M Kogevinas S Kvinnsland C La Vecchia F Levi JG McVie P Maisonneuve JM Martin-Moreno JN Bishop F Oleari P Perrin M Quinn M Richards U Ringborg C Scully E Siracka H Storm M Tubiana T Tursz U Veronesi N Wald W Weber DG Zaridze W Zatonski HH. zur (2003) ArticleTitleEuropean Code Against Cancer and scientific justification: 3rd version Ann Oncol 14 973–1005 Occurrence Handle10.1093/annonc/mdg305 Occurrence Handle12853336

    Article  PubMed  Google Scholar 

  2. MH Christiaans JC Kelder EP Arnoldus CC. Tijssen (2002) ArticleTitlePrediction of intracranial metastases in cancer patients with headache Cancer 94 2063–2068 Occurrence Handle10.1002/cncr.10379 Occurrence Handle11932910

    Article  PubMed  Google Scholar 

  3. R Soffietti R Ruda R. Mutani (2002) ArticleTitleManagement of brain metastases J Neurol 249 1357–1369 Occurrence Handle10.1007/s00415-002-0870-6 Occurrence Handle12382150

    Article  PubMed  Google Scholar 

  4. P. Davey (2002) ArticleTitleBrain metastases: treatment options to improve outcomes CNS Drugs 16 325–338 Occurrence Handle11994022

    PubMed  Google Scholar 

  5. MA Herman I Tremont-Lukats CA Meyers DD Trask C Froseth MF Renschler MP. Mehta (2003) ArticleTitleNeurocognitive and functional assessment of patients with brain metastases: a pilot study Am J Clin Oncol 26 273–279 Occurrence Handle10.1097/00000421-200306000-00014 Occurrence Handle12796600

    Article  PubMed  Google Scholar 

  6. MP Mehta P Rodrigus CH Terhaard A Rao J Suh W Roa L Souhami A Bezjak M Leibenhaut R Komaki C Schultz R Timmerman W Curran J Smith SC Phan RA Miller MF. Renschler (2003) ArticleTitleSurvival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases J Clin Oncol 21 2529–2536 Occurrence Handle10.1200/JCO.2003.12.122 Occurrence Handle12829672

    Article  PubMed  Google Scholar 

  7. WF Regine C Scott K Murray W. Curran (2001) ArticleTitleNeurocognitive outcome in brain metastases patients treated with accelerated-fractionation vs. accelerated-hyperfractionated radiotherapy: an analysis from Radiation Therapy Oncology Group Study 91-04 Int J Radiat Oncol Biol Phys 51 711–717 Occurrence Handle10.1016/S0360-3016(01)01676-5 Occurrence Handle11597813

    Article  PubMed  Google Scholar 

  8. PD Schellinger HM Meinck A. Thron (1999) ArticleTitleDiagnostic accuracy of MRI compared to CCT in patients with brain metastases J Neurooncol 44 275–281 Occurrence Handle10.1023/A:1006308808769 Occurrence Handle10720207

    Article  PubMed  Google Scholar 

  9. P Van Dijk PE Sijens PI Schmitz M. Oudkerk (1997) ArticleTitleGd-enhanced MR imaging of brain metastases: contrast as a function of dose and lesion size Magn Reson Imaging 15 535–541 Occurrence Handle10.1016/S0730-725X(97)00015-5 Occurrence Handle9253997

    Article  PubMed  Google Scholar 

  10. WT Yuh ET Tali HD Nguyen TM Simonson NA Mayr DJ. Fisher (1995) ArticleTitleThe effect of contrast dose, imaging time, and lesion size in the MR detection of intracerebral metastasis AJNR Am J Neuroradiol 16 373–380 Occurrence Handle7726087

    PubMed  Google Scholar 

  11. WT Yuh DJ Fisher VM Runge SW Atlas SE Harms KR Maravilla NA Mayr JE Mollman AC. Price (1994) ArticleTitlePhase III multicenter trial of high-dose gadoteridol in MR evaluation of brain metastases AJNR Am J Neuroradiol 15 1037–1051 Occurrence Handle8073972

    PubMed  Google Scholar 

  12. A Ba-Ssalamah IM Nobauer-Huhmann K Pinker N Schibany R Prokesch S Mehrain V Mlynarik A Fog K Heimberger S. Trattnig (2003) ArticleTitleEffect of contrast dose and field strength in the magnetic resonance detection of brain metastases Invest Radiol 38 415–422 Occurrence Handle10.1097/00004424-200307000-00006 Occurrence Handle12821855

    Article  PubMed  Google Scholar 

  13. RA Patchell PA Tibbs JW Walsh RJ Dempsey Y Maruyama RJ Kryscio WR Markesbery JS Macdonald B. Young (1990) ArticleTitleA randomized trial of surgery in the treatment of single metastases to the brain N Engl J Med 322 494–500 Occurrence Handle2405271

    PubMed  Google Scholar 

  14. W Moller-Hartmann S Herminghaus T Krings G Marquardt H Lanfermann U Pilatus FE. Zanella (2002) ArticleTitleClinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions Neuroradiology 44 371–381 Occurrence Handle10.1007/s00234-001-0760-0 Occurrence Handle12012120

    Article  PubMed  Google Scholar 

  15. H Ishimaru M Morikawa S Iwanaga M Kaminogo M Ochi K. Hayashi (2001) ArticleTitleDifferentiation between high-grade glioma and metastatic brain tumor using single-voxel proton MR spectroscopy Eur Radiol 11 1784–1791 Occurrence Handle10.1007/s003300000814 Occurrence Handle11511902

    Article  PubMed  Google Scholar 

  16. B Klee I Law L Hojgaard M. Kosteljanetz (2002) ArticleTitleDetection of unknown primary tumours in patients with cerebral metastases using whole-body 18F-flouorodeoxyglucose positron emission tomography Eur J Neurol 9 657–662 Occurrence Handle10.1046/j.1468-1331.2002.00467.x Occurrence Handle12453082

    Article  PubMed  Google Scholar 

  17. BM Fischer J Mortensen L. Hojgaard (2001) ArticleTitlePositron emission tomography in the diagnosis and staging of lung cancer: a systematic, quantitative review Lancet Oncol 2 659–666 Occurrence Handle10.1016/S1470-2045(01)00555-1 Occurrence Handle11902536

    Article  PubMed  Google Scholar 

  18. EM Rohren JM Provenzale DP Barboriak RE. Coleman (2003) ArticleTitleScreening for cerebral metastases with FDG PET in patients undergoing whole-body staging of non-central nervous system malignancy Radiology 226 181–187 Occurrence Handle12511688

    PubMed  Google Scholar 

  19. R Ruda M Borgognone F Benech E Vasario R. Soffietti (2001) ArticleTitleBrain metastases from unknown primary tumour: a prospective study J Neurol 248 394–398 Occurrence Handle10.1007/s004150170180 Occurrence Handle11437161

    Article  PubMed  Google Scholar 

  20. M Pol Particlevan de VC Aalst Particlevan JT Wilmink A. Twijnstra (1996) ArticleTitleBrain metastases from an unknown primary tumour: which diagnostic procedures are indicated? J Neurol Neurosurg Psychiatry 61 321–323 Occurrence Handle8795609

    PubMed  Google Scholar 

  21. M Lorberboym LR Mandell RE Mosesson I Germano W Lou M DaCosta DG Linzer J. Machac (1997) ArticleTitleThe role of thallium-201 uptake and retention in intracranial tumors after radiotherapy J Nucl Med 38 223–226 Occurrence Handle9025741

    PubMed  Google Scholar 

  22. M Essig M Waschkies F Wenz J Debus HR Hentrich MV. Knopp (2003) ArticleTitleAssessment of brain metastases with dynamic susceptibility-weighted contrast-enhanced MR imaging: initial results Radiology 228 193–199 Occurrence Handle12832582

    PubMed  Google Scholar 

  23. LE Gaspar C Scott K Murray W. Curran (2000) ArticleTitleValidation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases Int J Radiat Oncol Biol Phys 47 1001–1006 Occurrence Handle10.1016/S0360-3016(00)00547-2 Occurrence Handle10863071

    Article  PubMed  Google Scholar 

  24. FJ Lagerwaard PC Levendag PJ Nowak WM Eijkenboom PE Hanssens PI. Schmitz (1999) ArticleTitleIdentification of prognostic factors in patients with brain metastases: a review of 1292 patients Int J Radiat Oncol Biol Phys 43 795–803 Occurrence Handle10.1016/S0360-3016(98)00442-8 Occurrence Handle10098435

    Article  PubMed  Google Scholar 

  25. J Lutterbach S Bartelt C. Ostertag (2002) ArticleTitleLong-term survival in patients with brain metastases J Cancer Res Clin Oncol 128 417–425 Occurrence Handle10.1007/s00432-002-0354-1 Occurrence Handle12200598

    Article  PubMed  Google Scholar 

  26. C Nieder N Andratschke AL Grosu M. Molls (2003) ArticleTitleRecursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases Strahlenther Onkol 179 16–20 Occurrence Handle10.1007/s00066-003-1028-x Occurrence Handle12540980

    Article  PubMed  Google Scholar 

  27. L Ostergaard FH Hochberg JD Rabinov AG Sorensen M Lev L Kim RM Weisskoff RG Gonzalez C Gyldensted BR. Rosen (1999) ArticleTitleEarly changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors J Neurosurg 90 300–305 Occurrence Handle9950501

    PubMed  Google Scholar 

  28. CJ Vecht A Hovestadt HB Verbiest JJ Vliet Particlevan WL. Putten Particlevan (1994) ArticleTitleDose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors: a randomized study of doses of 4, 8, and 16 mg per day Neurology 44 675–680 Occurrence Handle8164824

    PubMed  Google Scholar 

  29. MJ Glantz BF Cole MH Friedberg E Lathi H Choy K Furie W Akerley L Wahlberg A Lekos S. Louis (1996) ArticleTitleA randomized, blinded, placebo-controlled trial of divalproex sodium prophylaxis in adults with newly diagnosed brain tumors Neurology 46 985–991 Occurrence Handle8780077

    PubMed  Google Scholar 

  30. MJ Glantz BF Cole PA Forsyth LD Recht PY Wen MC Chamberlain SA Grossman JG. Cairncross (2000) ArticleTitlePractice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors.Report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology 54 1886–1893 Occurrence Handle10822423

    PubMed  Google Scholar 

  31. CJ Vecht GL Wagner EB. Wilms (2003) ArticleTitleInteractions between antiepileptic and chemotherapeutic drugs Lancet Neurol 2 404–409 Occurrence Handle10.1016/S1474-4422(03)00435-6 Occurrence Handle12849118

    Article  PubMed  Google Scholar 

  32. GL Wagner EB Wilms CA Van Donselaar CJ. Vecht (2003) ArticleTitleLevetiracetam: preliminary experience in patients with primary brain tumours Seizure 12 585–586 Occurrence Handle10.1016/S1059-1311(03)00096-7 Occurrence Handle14630498

    Article  PubMed  Google Scholar 

  33. SD Shorvon A Lowenthal D Janz E Bielen P. Loiseau (2000) ArticleTitleMulticenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures European Levetiracetam Study Group. Epilepsia 41 1179–1186

    Google Scholar 

  34. E. Ben Menachem (2003) ArticleTitlePreliminary efficacy of levetiracetam in monotherapy Epileptic Disord 5 IssueIDS51 S51–S55

    Google Scholar 

  35. LA Rogers (2002) Cerebrovascular disease VA Levin (Eds) Cancer in the nervous system Oxford University Press New York 454–469

    Google Scholar 

  36. AD Levi MC Wallace M Bernstein BC. Walters (1991) ArticleTitleVenous thromboembolism after brain tumor surgery: a retrospective review Neurosurgery 28 859–863 Occurrence Handle10.1097/00006123-199106000-00012 Occurrence Handle2067609

    Article  PubMed  Google Scholar 

  37. R Sawaya M Zuccarello M Elkalliny H. Nishiyama (1992) ArticleTitlePostoperative venous thromboembolism and brain tumors: Part I Clinical profile. J Neurooncol 14 119–125

    Google Scholar 

  38. D Schiff LM. DeAngelis (1994) ArticleTitleTherapy of venous thromboembolism in patients with brain metastases Cancer 73 493–498 Occurrence Handle8293418

    PubMed  Google Scholar 

  39. J Kelly BJ Hunt RR Lewis A. Rudd (2003) ArticleTitleAnticoagulation or inferior vena cava filter placement for patients with primary intracerebral hemorrhage developing venous thromboembolism? Stroke 34 2999–3005 Occurrence Handle10.1161/01.STR.0000102561.86835.17 Occurrence Handle14615615

    Article  PubMed  Google Scholar 

  40. PG Lawlor B Gagnon IL Mancini JL Pereira J Hanson ME Suarez-Almazor Bruera (2000) ArticleTitleOccurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study Arch Intern Med 160 786–794 Occurrence Handle10.1001/archinte.160.6.786 Occurrence Handle10737278

    Article  PubMed  Google Scholar 

  41. SB Gelfand J Indelicato J. Benjamin (1992) ArticleTitleUsing intravenous haloperidol to control delirium Hosp Community Psych 43 215

    Google Scholar 

  42. DK Payne MJ Massie (1998) Depression and anxiety AM Berger R K Portenoy DE Weissman (Eds) Supportive Oncology Lippincott-Raven Philadelphia 497–511

    Google Scholar 

  43. NS Litofsky E Farace F Anderson SuffixJr. CA Meyers W Huang ER Laws SuffixJr. (2004) ArticleTitleDepression in patients with high-grade glioma: results of the Glioma Outcomes Project Neurosurgery 54 358–366 Occurrence Handle10.1227/01.NEU.0000103450.94724.A2 Occurrence Handle14744282

    Article  PubMed  Google Scholar 

  44. D Costa I Mogos T. Toma (1985) ArticleTitleEfficacy and safety of mianserin in the treatment of depression of women with cancer Acta Psychiat Scand 320 85–92

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Medical Center Haaglanden, P.O. Box 432, 2501, CK, The Hague, Netherlands

    Evert C. A. Kaal, Martin J. B. Taphoorn & Charles J. Vecht

Authors
  1. Evert C. A. Kaal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Martin J. B. Taphoorn
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Charles J. Vecht
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Charles J. Vecht.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kaal, E.C.A., Taphoorn, M.J.B. & Vecht, C.J. Symptomatic management and imaging of brain metastases. J Neurooncol 75, 15–20 (2005). https://doi.org/10.1007/s11060-004-8094-5

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-004-8094-5

Keywords

Search

Navigation